Chinese investment is fueling a flush funding market for Western biotech firms—and concerns about valuation and riskhttps://on.wsj.com/2LPQiN6
1 reply
19 retweets
28 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.